Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025

Company Announcement - Lexicon Pharmaceuticals, Inc. will release its second quarter 2025 financial results on August 6, 2025, prior to market open [1] - Management will conduct a conference call and live webcast at 8:30 a.m. ET on the same day to discuss the financial results and provide a business update [1] Conference Call Details - Participants can access the conference call live via webcast on the Company's website [2] - Those wishing to ask questions may register to receive dial-in numbers and a unique pin to join the call [2] - An archived version of the webcast will be available on the Lexicon website [2] Company Overview - Lexicon is a biopharmaceutical company focused on pioneering medicines that transform patients' lives [3] - The Genome5000™ program has enabled Lexicon scientists to study nearly 5,000 genes, identifying over 100 protein targets with significant therapeutic potential [3] - The company has advanced multiple medicines to market and has a pipeline of promising drug candidates in various therapeutic areas including heart failure, neuropathic pain, obesity, cardiology, and diabetes [3]